
Europe Establishes Its First Clinical Guide for Photobiomodulation in Cancer Care
Feb 14, 2026
A deep dive into photobiomodulation, the red and near‑infrared light therapy gaining clinical traction. Coverage of Europe’s new oncology clinical guide and which cancer complications benefit most. Explanations of wavelengths, dosing, device types, and safety. Discussion of broader uses from wound healing to musculoskeletal recovery and how to choose validated equipment and protocols.
AI Snips
Chapters
Transcript
Episode notes
Europe's First Oncology PBM Guide
- Europe released its first formal clinical PBM guide for oncology to standardize supportive care across centers.
- The guide focuses on consistency so patients get the same PBM protocols regardless of clinic.
Use PBM To Prevent Treatment Interruptions
- Use PBM to reduce oral mucositis and radiation-related skin damage to keep cancer treatment on schedule.
- Ask your oncology team about integrating PBM when mouth pain or skin breakdown threatens eating or treatment continuity.
Wavelengths Determine PBM Depth
- PBM uses low-intensity red and near-infrared light without heat to target tissues.
- Red targets superficial tissue while near-infrared penetrates deeper within an optical window of ~600–900 nm.
